Cochlear Limited
Cochlear Limited (CHEOF) Revenue
Annual & quarterly revenue history · segment & region breakdown
CHEOF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsCochlear Limited trailing twelve-month (TTM) revenue is $4.67B, an increase of 4.81% year-over-year from $2.34B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-06-30 | $2.34B | +$0.11B | +4.81% |
| 2024-06-30 | $2.24B | +$0.30B | +15.47% |
| 2023-06-30 | $1.94B | +$0.29B | +17.46% |
| 2022-06-30 | $1.65B | +$0.15B | +10.06% |
| 2021-06-30 | $1.50B | +$0.18B | +13.40% |
| 2020-06-30 | $1.32B | -$0.11B | -7.44% |
| 2019-06-30 | $1.43B | +$0.06B | +4.62% |
| 2018-06-30 | $1.36B | +$0.11B | +8.76% |
| 2017-06-30 | $1.25B | +$0.12B | +10.90% |
| 2016-06-30 | $1.13B | +$0.20B | +22.14% |
Compare revenue vs peers
Medical - DevicesCompare CHEOF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Cochlear Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Cochlear Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in AUD.
Data sourced from Cochlear Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CHEOF revenue · 4 questionsCHEOF's trailing twelve-month (TTM) revenue is $4.67B. That is an increase of 4.81% year-over-year from $2.34B in FY2025.
▸ Source: FMP · Cochlear Limited SEC filings · GAAP · Cochlear Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026